Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_assertion type Assertion NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_head.
- NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_provenance.
- NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_assertion evidence source_evidence_literature NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_provenance.
- NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_assertion SIO_000772 11145579 NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_provenance.
- NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_assertion wasDerivedFrom befree-20140225 NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_provenance.
- NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_assertion wasGeneratedBy ECO_0000203 NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_provenance.